DaehanPharmaceutical

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

2.93%

Shrs. gr., 5y

—

Rev. gr., 5y

6.31%

Revenues

Net income

CFO

Dividend

Dec 29, 2025900 KRW/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Dai Han Pharm. Co., Ltd. manufactured the first infusion as the basis of the national health, opening a new horizon for medical companies and grew as a representative infusion manufacturer of Korea

URL

https://www.daihan.com/main/main.php

IPO date

Nov 23, 1994

Employees

Domiciled in

Incorporated in

Valuation

No data to show